Click Therapeutics Stock Price, Funding, Valuation, Revenue

Nov 6, 2023 · Funding, Valuation & Revenue. Click Therapeutics has raised $142.58M over 11 rounds. Click Therapeutics's latest funding round was a Debt - V for $20M on November 6, …

CouponFollow Extension

$142.58
OFF

Click Therapeutics Stock Price, Funding, Valuation, Revenue

6 days from now

Nov 6, 2023 · Funding, Valuation & Revenue. Click Therapeutics has raised $142.58M over 11 rounds. Click Therapeutics's latest funding round was a Debt - V for $20M on November 6, …

cbinsights.com

$41
OFF

Click Therapeutics: Revenue, Competitors, Alternatives - Growjo

6 days from now

Click Therapeutics top competitors are Buffalo BioLabs, KSL Diagnostics and Genencor International and they have annual revenue of $41.7M and 215 employees. ... Estimated …

growjo.com

$0.93
OFF

Click Therapeutics Stock $0.93 | How To Buy, Valuation, Stock Price ...

6 days from now

Nov 16, 2024 · See real-time Click Therapeutics price charts, funding & market data. Connect with the world's best Click Therapeutics brokers to learn how to buy Click Therapeutics stock. …

notice.co

$78
OFF

Click Therapeutics - Company Profile - Tracxn

6 days from now

Oct 23, 2024 · Click Therapeutics - Provider of mobile apps for treatment of brain disorders. Raised a total funding of $78.7M over 10 rounds from 12 investors. ... How much funding has …

tracxn.com

$78
OFF

Click Therapeutics - Raised $78.7M Funding From 12 Investors

6 days from now

Nov 5, 2024 · Click Therapeutics has raised a total funding of $78.7M over 10 rounds from 12 investors. Investors include SVB, Sanofi Ventures and 10 others. Their latest funding round …

tracxn.com

$52
OFF

Click Therapeutics® – Funding, Valuation, Investors, News

6 days from now

May 22, 2024 · 22.10.2021. Click Therapeutics Completes $52 Million Series B Financing Co-Led by H.I.G. BioHealth Partners and Accelmed Partners. Click Therapeutics, Inc. (“Click”), a …

parsers.vc

$17500000
OFF

Click Therapeutics Stock - Private Shares Fund

6 days from now

Healthcare/Biotech | Founded: 2012 | Funding to Date: $17,500,000. Click Therapeutics develops and commercializes software as prescription medical treatments for people with unmet …

privatesharesfund.com

$25.35
OFF

Click Therapeutics Company Profile - Office Locations ... - Craft

6 days from now

Click Therapeutics has 5 employees across 4 locations and $25.35 m in total funding,. See insights on Click Therapeutics including office locations, competitors, revenue, financials, …

craft.co

$52
OFF

Click Therapeutics Completes $52 Million Series B Financing Co …

6 days from now

Oct 22, 2021 · NEW YORK--Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, today announced that it has closed a $52 million upsized …

clicktherapeutics.com

$525060
OFF

Click Holdings Limited (CLIK) Statistics & Valuation Metrics - Stock ...

6 days from now

3 days ago · Balance Sheet. The company has $525,060 in cash and $630,083 in debt, giving a net cash position of -$105,023 or -$0.01 per share. Cash & Cash Equivalents. 525,060. Total …

stockanalysis.com

$19.14
OFF

CTRL Therapeutics Stock Price, Funding, Valuation, Revenue

6 days from now

Sep 26, 2024 · cTRL Therapeutics has raised $19.14M over 3 rounds. cTRL Therapeutics's latest funding round was a Seed for $9.14M on September 26, 2024. Date. Round. Amount. …

cbinsights.com

$75
OFF

GC Therapeutics Stock Price, Funding, Valuation, Revenue

6 days from now

Oct 2, 2024 · Funding, Valuation & Revenue. GC Therapeutics has raised $75M over 5 rounds. GC Therapeutics's latest funding round was a Series A - II for on October 2, 2024. Valuations …

cbinsights.com

17%
OFF

Sangamo Therapeutics Inc (SGMO) Q3 2024 Earnings Call …

6 days from now

Nov 13, 2024 · SoundHound AI Stock Sinks 17% Despite Beating Earnings and Revenue Estimates and Raising 2024 and 2025 Guidance. In Q3 2024, the AI-powered voice solutions …

yahoo.com

FAQs about Click Therapeutics Stock Price, Funding, Valuation, Revenue Coupon?

How much money has click Therapeutics raised over 12 rounds?

Click Therapeutics has raised $142.58M over 12 rounds. Click Therapeutics's latest funding round was a Debt - V for $20M on November 6, 2023. Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. ...

How many investors does click therapeutics have?

Click Therapeutics's deal structure is available for 1 funding round, including their Series A from June 28, 2018. Click Therapeutics has 14 investors. HSBC Innovation Banking invested in Click Therapeutics's Debt - V funding round. Click Therapeutics acquired 1 company. Their latest acquisition was Pear Therapeutics on May 19, 2023. ...

Who are the owners of Click Therapeutics?

Click Therapeutics is owned by 15 investors. The most recent investors are Silicon Valley Bank and Hikma Ventures. According to PrivCo, Click Therapeutics has a post-money valuation in the range of $100M to $500M as of Oct 22, 2021. ...

Where is click Therapeutics located?

Click Therapeutics is located in New York, New York, United States. Who invested in Click Therapeutics? Click Therapeutics has 16 investors including HSBC Innovation Banking and Silicon Valley Bank. How much funding has Click Therapeutics raised to date? Click Therapeutics has raised . When was the last funding round for Click Therapeutics? ...

Who is click Therapeutics's co-founder & CEO?

Click Therapeutics's Co-Founder & CEO, David Benshoof Klein, currently has an approval rating of 85%. Click Therapeutics's primary competitors are Better Therapeutics, Huma, Akili and 10 more. View 13 Click Therapeutics competitors here. View Click Therapeutics funding details. When was Click Therapeutics founded? Who is Click Therapeutics's CEO? ...

What is the post-money valuation of click Therapeutics?

According to PrivCo, Click Therapeutics has a post-money valuation in the range of $100M to $500M as of Oct 22, 2021. Sign up for a free trial to view the exact valuation and search companies with similar valuations. Click Therapeutics acquired ProGevity Neuroscience on Aug 6, 2012. ...